Myocardial Infarction Summary

Networked: 59124 relevant articles (3091 outcomes, 10702 trials/studies) for this Disease

Key Drugs and Agents for Myocardial Infarction

1. Aspirin (Acetylsalicylic Acid) : 144 outcomes 445 studies in 1668 results : FDA 80 Generic
   
2. Heparin (Liquaemin) : 90 outcomes 246 studies in 971 results : FDA 74 Generic
   
3. clopidogrel (Plavix) : 89 outcomes 257 studies in 802 results : FDA 7
   
4. Streptokinase : 88 outcomes 325 studies in 1348 results : FDA 1
   
5. glucuronyl glucosamine glycan sulfate (Vessel) : 60 outcomes 233 studies in 2448 results : IBA
   
6. Glycoproteins (Glycoprotein) : 57 outcomes 134 studies in 542 results : IBA
   
7. Tissue Plasminogen Activator (Alteplase) : 56 outcomes 273 studies in 860 results : FDA 2
   
8. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) : 56 outcomes 183 studies in 789 results : IBA
   
9. prasugrel : 50 outcomes 77 studies in 155 results : IBA
   
10. Fibrinolytic Agents (Antithrombotic Agents) : 44 outcomes 81 studies in 475 results : IBA
    

Diseases Related to Myocardial Infarction

1. Stroke (Strokes)
2. Heart Failure
3. Unstable Angina
4. Thrombosis (Thrombus)
5. Acute Coronary Syndrome

Key Therapies for Myocardial Infarction

1. Thrombolytic Therapy : 196 outcomes 472 studies in 2755 results
   
2. Angioplasty (Angioplasty, Transluminal) : 170 outcomes 647 studies in 3207 results
   
3. Stents : 119 outcomes 531 studies in 2768 results
   
4. Transplantation (Transplant Recipients) : 96 outcomes 117 studies in 644 results
   
5. Coronary Artery Bypass (Coronary Artery Bypass Surgery) : 57 outcomes 251 studies in 2255 results